Medicare Enrolled
Dr. Robert Czyzewski, M.D.
Optician · Edison, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Czyzewski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Czyzewski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Czyzewski
Dr. Robert Czyzewski is an optician specialist in Edison, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Czyzewski performed 9,474 Medicare services across 2,311 unique beneficiaries.
Between the years covered by Open Payments, Dr. Czyzewski received a total of $10,514 from 58 pharmaceutical and/or device companies across 485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Czyzewski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in NJ
$10,514 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,474
Medicare services
Top 6% in NJ for optician
2,311
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~474 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
5,178 | $67 | $155 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
912 | $34 | $90 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
755 | $98 | $212 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
649 | $57 | $120 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
436 | $106 | $233 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
412 | $300 | $520 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
262 | $98 | $204 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
239 | $98 | $200 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
104 | $8 | $15 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
103 | $148 | $270 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $130 | $325 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
66 | $141 | $302 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
60 | $247 | $350 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
55 | $12 | $40 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
44 | $67 | $190 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
31 | $34 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
29 | $72 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $54 | $163 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
19 | $11 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
15 | $2 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,514
Total received (2018-2024)
Avg $1,502/year across 7 years
Top 9% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
485
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,417 (80.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,596 (15.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$501 (4.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,114
2023
$2,374
2022
$1,258
2021
$1,857
2020
$2,274
2019
$437
2018
$201
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$397
Amgen Inc.
$241
Ardelyx, Inc.
$166
Bayer Healthcare Pharmaceuticals Inc.
$157
Novartis Pharmaceuticals Corporation
$142
Dexcom, Inc.
$121
Exact Sciences Corporation
$118
ANI Pharmaceuticals, Inc.
$108
Otsuka America Pharmaceutical, Inc.
$74
GlaxoSmithKline, LLC.
$67
Travere Therapeutics, Inc.
$55
Lilly USA, LLC
$50
CVRx, Inc.
$49
Vifor Pharma, Inc.
$48
Aurinia Pharma U.S., Inc.
$45
AKEBIA THERAPEUTICS INC
$39
Medtronic, Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Abbott Laboratories
$26
ABBVIE INC.
$25
PFIZER INC.
$17
Merck Sharp & Dohme LLC
$16
Fresenius USA Marketing, Inc.
$16
Lundbeck LLC
$16
Corcept Therapeutics
$15
Mallinckrodt Hospital Products Inc.
$15
CALLIDITAS THERAPEUTICS US INC.
$15
Xeris Pharmaceuticals, Inc.
$14
Top 3 companies account for 38.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,642
Otsuka Pharmaceutical Development & Commercialization, Inc.
$1,596
Amgen Inc.
$825
Fresenius USA Marketing, Inc.
$509
Dexcom, Inc.
$481
OPKO Pharmaceuticals, LLC
$475
Horizon Therapeutics plc
$378
Lilly USA, LLC
$323
Bayer Healthcare Pharmaceuticals Inc.
$304
Baxter Healthcare
$300
Novartis Pharmaceuticals Corporation
$276
Otsuka America Pharmaceutical, Inc.
$269
Vifor Pharma, Inc.
$259
Exact Sciences Corporation
$204
ANI Pharmaceuticals, Inc.
$185
GlaxoSmithKline, LLC.
$184
Aurinia Pharma U.S., Inc.
$176
Intuity Medical Inc
$174
PFIZER INC.
$170
Ardelyx, Inc.
$166
Mallinckrodt Hospital Products Inc.
$152
Novo Nordisk Inc
$114
Bayer HealthCare Pharmaceuticals Inc.
$111
Exeltis, USA Inc.
$97
Travere Therapeutics, Inc.
$89
CALLIDITAS THERAPEUTICS US INC.
$71
Calliditas Therapeutics US Inc.
$65
AKEBIA THERAPEUTICS INC
$63
Medtronic, Inc.
$55
Merck Sharp & Dohme Corporation
$54
Relypsa, Inc.
$53
DEXCOM, INC.
$50
CVRx, Inc.
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Mallinckrodt Enterprises LLC
$42
AbbVie Inc.
$42
ABBVIE INC.
$38
Abbott Laboratories
$37
Amarin Pharma Inc.
$36
Merck Sharp & Dohme LLC
$32
AbbVie, Inc.
$28
Genentech USA, Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$27
Eisai Inc.
$25
Daiichi Sankyo Inc.
$24
Ultragenyx Pharmaceutical Inc.
$17
Lundbeck LLC
$16
Senseonics, Incorporated
$16
Acerus Pharmaceuticals Corporation
$15
Corcept Therapeutics
$15
Janssen Pharmaceuticals, Inc
$15
Phadia US Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Insulet Corporation
$14
SANOFI-AVENTIS U.S. LLC
$14
Xeris Pharmaceuticals, Inc.
$14
Shionogi Inc
$13
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · ArmonAir Digihaler · Auryxia · BASAGLAR · BELSOMRA · BENLYSTA · BREATHTEK · BRILINTA · Barostim Neo System · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · Creon · Crysvita · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · Eversense · FARXIGA · FREESTYLE LIBRE 3 · Fabhalta · FreeStyle Libre · GARDASIL · GATTEX · IBSRELA · INJECTAFER · ImmunoCAP · InPen · JANUVIA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · Korlym · Korsuva · LEQVIO · LOKELMA · LUPKYNIS · MINIMED 780G · MOUNJARO · Natesto · Omnipod · Otezla · Ozempic · PAXLOVID · PREMARIN · PURIFIED CORTROPHIN GEL · Parsabiv · Pogo Automatic Blood Glucose Monitoring System · RAYALDEE · RECORLEV · REXULTI · Rayaldee · Renal - Chronic · Repatha · Rituxan · Rybelsus · SHINGRIX · SOLIQUA · SPIRIVA RESPIMAT · Symproic · TARPEYO · TAVNEOS · TRELEGY ELLIPTA · TRULICITY · Tavneos · UBRELVY · ULTOMIRIS · Vafseo · Vascepa · Velphoro · Veltassa · Wegovy · XARELTO · XPHOZAH 30 MG · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for optician in NJ.
Geographic Context
Opticians within 10 mi
8,711
Per 100K population
1011.1
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Czyzewski is a mixed practice specialist, with above-average Medicare volume (top 6% in NJ), with low-engagement industry engagement in the top 9% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Czyzewski experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Czyzewski performed 5,178 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Czyzewski receive payments from pharmaceutical companies?
Yes. Dr. Czyzewski received a total of $10,514 from 58 companies across 485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Czyzewski's costs compare to other opticians in Edison?
Dr. Czyzewski's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Czyzewski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Edison
Browse opticians in Edison ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Otsuka Pharmaceutical Development & Commercialization, Inc. Payments to Doctors
See all physicians who received payments from Otsuka Pharmaceutical Development & Commercialization, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology